Nyenburgh Investment Partners Founded 2013
Founders
Overview
Portfolio analytics
Team
Investments
News & Media
Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 1
Average round size
info
The average size of a deal this fund participated in
$3M
Portfolio companies 1
Rounds per year 0.12
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
-
Exits -
Key employees -
Areas of investment
Biotechnology
Clinical Trials
Health Care
Summary

Nyenburgh Investment Partners is the famous VC, which was founded in 2013. The main office of represented VC is situated in the Amsterdam. The company was established in Europe in The Netherlands.

The typical case for the fund is to invest in rounds with 1 participant. Despite the Nyenburgh Investment Partners, startups are often financed by Vinnova, U.S. Department of Defense, Congressionally Directed Medical Research Programs.

The overall number of key employees were 2.

The important activity for fund was in 2019. The increased amount of exits for fund were in 2013. The fund is constantly included in less than 2 investment rounds annually. The usual things for fund are deals in the range of 1 - 5 millions dollars.

We can highlight the next thriving fund investment areas, such as Clinical Trials, Biotechnology. Besides, a startup needs to be aged 16-20 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight NeuroVive Pharmaceutical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Sweden.

Read more
Latest deals
CompanyIndustryRoundRound SizeDateInvestorsLocation
Abliva
Biotechnology
Clinical Trials
Health Care
Post-IPO Equity
3M07 Mar 2019 Sweden, Lund
Review
  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Nyenburgh Investment Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Crunchbase icon

Content report

The following text will be sent to our editors: